These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 20113653

  • 1. [Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma].
    Feng C, Tang SQ, Wang JW, Liu Y, Yang G.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):885-7. PubMed ID: 20113653
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF, Liu DG, Su YS, Lin TY, Chen XQ, He YJ.
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [Abstract] [Full Text] [Related]

  • 3. Neuroblastoma.
    Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [Abstract] [Full Text] [Related]

  • 4. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
    Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK.
    J Clin Oncol; 2004 Dec 15; 22(24):4888-92. PubMed ID: 15611504
    [Abstract] [Full Text] [Related]

  • 5. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
    Valteau-Couanet D, Michon J, Boneu A, Rodary C, Perel Y, Bergeron C, Rubie H, Coze C, Plantaz D, Bernard F, Chastagner P, Bouzy J, Hartmann O.
    J Clin Oncol; 2005 Jan 20; 23(3):532-40. PubMed ID: 15659499
    [Abstract] [Full Text] [Related]

  • 6. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.
    De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero Di Montezemolo L, Donfrancesco A, Pession A, Provenzi M, di Cataldo A, Rizzo A, Tonini GP, Dallorso S, Conte M, Gambini C, Garaventa A, Bonetti F, Zanazzo A, D'Angelo P, Bruzzi P, Italian Co-Operative Group for Neuroblastoma.
    J Clin Oncol; 2003 Apr 15; 21(8):1592-601. PubMed ID: 12697885
    [Abstract] [Full Text] [Related]

  • 7. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):227-30. PubMed ID: 11464891
    [Abstract] [Full Text] [Related]

  • 8. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Jan 15; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 9. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D, Vassal G, Pondarré C, Bonnay M, Benhamou E, Couanet D, Plantaz D, Hartmann O.
    Bone Marrow Transplant; 1996 Apr 15; 17(4):485-9. PubMed ID: 8722343
    [Abstract] [Full Text] [Related]

  • 10. Topotecan plus cyclophosphamide as maintenance chemotherapy for children with high-risk neuroblastoma in complete remission: short-term curative effects and toxicity.
    Feng C, Tang S, Wang J, Liu Y, Yang G.
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Aug 15; 33(8):1107-10. PubMed ID: 23996746
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of patients with advanced neuroblastoma surviving more than 5 years after initiation of an intensive Japanese protocol: a report from the Study Group of Japan for Treatment of Advanced Neuroblastoma.
    Iwafuchi M, Utsumi J, Tsuchida Y, Kaneko M, Matsuyama S, Ohnuma N, Taguchi N, Mugishima H, Yokoyama J, Sasaki S, Yoshioka A, Nagahara N, Fukuzawa M, Suita S.
    Med Pediatr Oncol; 1996 Dec 15; 27(6):515-20. PubMed ID: 8888810
    [Abstract] [Full Text] [Related]

  • 12. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS.
    Cancer; 2006 Apr 15; 106(8):1846-56. PubMed ID: 16541446
    [Abstract] [Full Text] [Related]

  • 13. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S, Tornesello A, Diociaiuti L, Pession A, Prete A, Rufini V, Troncone L, Mastrangelo R.
    Br J Cancer; 2001 Feb 15; 84(4):460-4. PubMed ID: 11207038
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma.
    Garaventa A, Luksch R, Biasotti S, Severi G, Pizzitola MR, Viscardi E, Prete A, Mastrangelo S, Podda M, Haupt R, De Bernardi B.
    Cancer; 2003 Dec 01; 98(11):2488-94. PubMed ID: 14635085
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF, Zhen ZJ, Liu DG, Xia Y, Xiang XJ, Chen XQ, Ling JY, Zheng L, Luo WB, Lin H, He YJ, Guan ZZ.
    Ai Zheng; 2007 Dec 01; 26(12):1339-43. PubMed ID: 18076797
    [Abstract] [Full Text] [Related]

  • 16. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 17. [Multidisciplinary treatment of advanced neuroblastoma--experience in treatment with the protocol of a group study supported by a grant from Ministry of Health and Welfare].
    Ikeda H, Nagashima K, Matsuyama S, Okumura H, Nagamachi Y.
    Gan No Rinsho; 1988 Jul 01; 34(8):953-60. PubMed ID: 3136259
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of advanced neuroblastoma by the protocol of the Welfare Ministry used by the Sawaguchi Group].
    Shida S, Arioka H, Hatayama Y, Nakadate H, Hatae Y, Takeda T.
    Gan To Kagaku Ryoho; 1988 Mar 01; 15(3):425-9. PubMed ID: 3348628
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
    Kuroda T, Morikawa N, Matsuoka K, Fujino A, Honna T, Nakagawa A, Kumagai M, Masaki H, Saeki M.
    J Pediatr Surg; 2008 Dec 01; 43(12):2182-5. PubMed ID: 19040931
    [Abstract] [Full Text] [Related]

  • 20. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K, Fukuda M, Miyajima Y, Matsumoto K, Kondo M, Inaba J, Miyashita Y.
    Med Pediatr Oncol; 2001 Jan 01; 36(1):203-4. PubMed ID: 11464885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.